Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
8.04
-3.62 (-31.05%)
At close: Mar 18, 2026, 4:00 PM EDT
8.01
-0.03 (-0.37%)
After-hours: Mar 18, 2026, 7:59 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $93.49 million as of March 18, 2026. Its market cap has increased by 616.85% in one year.
Market Cap
93.49M
Enterprise Value
90.05M
1-Year Change
616.85%
Ranking
Category
Stock Price
$8.04
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $93.49M, an increase of 45.44%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 121.48M | 314.24% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 84.98M |
| PMV Pharmaceuticals | 83.19M |
| PolyPid | 83.01M |
| Pliant Therapeutics | 82.35M |
| Kazia Therapeutics | 82.05M |
| Annovis Bio | 77.69M |
| Pelthos Therapeutics | 77.17M |
| NeurAxis | 76.81M |